Dr. Petros Karakousis is a Professor of Medicine at the Johns Hopkins University School of Medicine. He has a joint appointment in International Health at the Johns Hopkins Bloomberg School of Public Health. He graduated summa cum laude from the Johns Hopkins University in 1994 and received a full-tuition, merit-based Nicholas Kouchoukos, MD Distinguished Alumni Scholarship to study at the Washington University School of Medicine in St. Louis, where he was inducted into the Alpha Omega Alpha Honor Society in 1998. He completed residency training in Internal Medicine in 2001 at the Hospital of the University of Pennsylvania, where he received the Maurice F. Attie Junior Resident Teaching Award and Edward W. Holmes Resident Research Award. After completing fellowship training in Infectious Diseases at the Johns Hopkins University School of Medicine, he joined the Department of Medicine faculty at the same institution in 2005. Dr. Karakousis was named a Fellow of the Infectious Diseases Society of America in 2010, and has held numerous leadership positions, including in the Working Group on New TB Drugs of the Stop TB Partnership. He has served on the editorial board of various scientific journals and on numerous NIH study sections, and as a peer reviewer for many international government and private funding agencies. As an example of the scope of his work, his Lab has conducted extensive prclinical studies characterizing the host-directed activities of statins and other immunomodulatory agents against Mycobacterium tuberculosis, and he has led a randomized clinical trial to test the activity of pravastatin as adjunctive, host-directed therapy in patients with TB/HIV co-infection in South Africa.